Identify the INCORRECT statement about the biomarkers in pre-eclampsia.
A. Placental Protein 13 (PP13) is involved in normal placentation
B. sFlt1 level is increased in severe pre-eclampsia
C. sFlt1 to PIGF (Placental Growth Factor) ratio can be used in risk stratification in women with suspected pre-eclampsia
D. Urinary levels of PIGF are significantly higher in women who develop pre-eclampsia
Answer:D
Identify the INCORRECT statement about the biomarkers in pre-eclampsia.
A. Placental Protein 13 (PP13) is involved in normal placentation B. sFlt1 level is increased in severe pre-eclampsia C. sFlt1 to PIGF (Placental Growth Factor) ratio can be used in risk stratification in women with suspected pre-eclampsia D. Urinary levels of PIGF are significantly higher in women who develop pre-eclampsia